PRTG - נכסי מאזן של החברה Portage Biotech Inc

Portage Biotech Inc. (PRTG) focuses on developing universal methods to combat metastases and solid tumors through the activation of iNKT cells. However, the current financial moat is limited to initial tests, and the freezing of several projects indicates a liquidity shortage. The historical price action of total assets on GURU.Markets, which currently stands at 49.31, illustrates the platform's potential to modify the tumor microenvironment to stimulate an immune response.

When constructing a long-term portfolio, it is critical to exclude assets with systemic resource degradation; therefore, a reverse calculation via ROA allows for the precise determination of the actual asset volume of Portage Biotech Inc. (PRTG) to assess its solvency. In biopharmaceuticals, where growth depends on regulatory approvals rather than macro cycles, total assets serve as an indicator of the company's ability to fund research, which this chart clearly illustrates.